Orifarm Group AS - Strategic SWOT Analysis Review

Orifarm Group AS - Strategic SWOT Analysis Review

  • Products Id :- GDPH359230SA
  • |
  • Pages: 22
  • |
  • |
  • |
  Request for Sample Report
  Request A Quote

Executive Summary

Orifarm Group AS-Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.


- Business description-A detailed description of the company's operations and business divisions.

- Corporate strategy-GlobalData's summarization of the company's business strategy.

- SWOT analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.

- Company history-Progression of key events associated with the company.

- Major products and services-A list of major products, services and brands of the company.

- Key competitors-A list of key competitors to the company.

- Key employees-A list of the key executives of the company.

- Executive biographies-A brief summary of the executives' employment history.

- Key operational heads-A list of personnel heading key departments/functions.

- Important locations and subsidiaries-A list of key locations and subsidiaries of the company, including contact details.

- Key manufacturing facilities-A list of key manufacturing facilities of the company.


Orifarm Group A/S (Orifarm Group) is a parallel importer of pharmaceuticals and supplier of pharmaceuticals. It comprises of several companies engaged in the import, manufacture, re-packaging, distribution, registration and commercialization of pharmaceuticals in the UK, Scandinavia, Germany, Holland and Czech Republic. The company parallel imports pharmaceuticals from European (EU) countries and are sold in Sweden, Finland, Holland, Denmark, Norway, Germany and the UK. Orifarm Group also sells generic pharmaceuticals in the Nordics. It sells a range of generic over-the-counter (OTC) products under Taek gult and Tank Gult brands. Orifarm Group is headquartered in Odense, Denmark.

Reasons to buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.

- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy.

- Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.

- Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Read More

Contact Us:
Ken Research
Ankur Gupta, Head Marketing & Communications


Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Orifarm Group A/S-Key Facts 5

Orifarm Group A/S-Key Employees 6

Orifarm Group A/S-Major Products and Services 7

Orifarm Group A/S-History 8

Orifarm Group A/S-Company Statement 9

Orifarm Group A/S-Locations And Subsidiaries 10

Head Office 10

Other Locations & Subsidiaries 10

Section 2-Company Analysis 11

Company Overview 11

Orifarm Group A/S-Business Description 12

Business Segment: Orifarm Generics Segment 12

Overview 12

Performance 12

Business Segment: Orifarm Parallel Import Segment 12

Overview 12

Performance 12

Orifarm Group A/S-Corporate Strategy 13

Orifarm Group A/S-SWOT Analysis 14

SWOT Analysis-Overview 14

Orifarm Group A/S-Strengths 14

Orifarm Group A/S-Weaknesses 15

Orifarm Group A/S-Opportunities 16

Orifarm Group A/S-Threats 17

Orifarm Group A/S-Key Competitors 18

Section 3-Company's Lifesciences Financial Deals and Alliances 19

Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 19

Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 20

Orifarm Group A/S, Recent Deals Summary 21

Section 4-Appendix 22

Methodology 22

About GlobalData 22

Contact Us 22

Disclaimer 22

List of Figures

Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 19

Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 20

List of Tables

Orifarm Group A/S, Key Facts 5

Orifarm Group A/S, Key Employees 6

Orifarm Group A/S, Major Products and Services 7

Orifarm Group A/S, History 8

Orifarm Group A/S, Subsidiaries 10

Orifarm Group A/S, Key Competitors 18

Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 19

Orifarm Group A/S, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 20

Orifarm Group A/S, Recent Deals Summary 21

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to sales [@] kenresearch.com

Straumann Danmark ApS

ScanimalHealth ApS

Paranova Group A/S

Falck Hjemmepleje A/S

Acino International AG

Orifarm Group AS, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Overview, Key Manufacturing Facilities, Key Information, Overview, Business Description, Major Products and Services, Brands, History, Key Employees, Key Employee Biographies, Key Operational Heads, Locations And Subsidiaries, Competitors, Company Statement.

select a license
Single User License
USD 125 INR 8920
Site License
USD 250 INR 17840
Corporate User License
USD 375 INR 26760



The report was very informative and gives me an interesting view on the Indian market....

We would like to thank the entire team of Ken Research in showcasing professionalism in research and quick turnaround time. We have had multiple research reports from Ken Research. The deadline communicated for research was duly met. The research reports were covering many aspects in detail. This showcases their endeavor and care for client satisfaction and a strong understanding of the clients’ requirements. Thank you again for your help...

I appreciate their diligence and determination in customizing the research project. The data proves to be valuable and accurate. I would, in future, definitely use their services again...

I would like to thank Ken research team for meeting our report deliverables. The report is very good and we appreciate your well cooperation. ...

The research you conducted was very helpful for us and the integrity of your research approach gave us great confidence in the data. Look forward to collaborating again in future...

Ken Research Private Limited, Unit 14, Tower B3, Spaze I Tech Business Park, Sohna Road, sector 49
     Gurgaon, Haryana - 122001, India


Company Brochure

Engage with Us

sales [@] kenresearch.com